Janney Montgomery Scott
CYTR

Janney Montgomery Scott’s CytRx Corp CYTR Stock Holding History

Janney Montgomery Scott’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,750
Closed -$69K – 2362
2014
Q2 		$69K Buy
2,750
+281
+11% +$6.41K ﹤0.01% 2154
2014
Q1 		$51.7K Buy
+2,469
New +$87.6K ﹤0.01% 2003

Other funds holding CYTR

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Janney Montgomery Scott's CYTR Position: Q3 2014 in Review

Janney Montgomery Scott sold out of CytRx Corp (CYTR) in Q3 2014, closing a stake of 2,750 shares — an estimated $69K sold.

Janney Montgomery Scott first reported a position in CYTR in Q1 2014 and held it in 2 quarters. The position peaked at $69K in Q2 2014. 69 funds tracked by Wall St. Rank hold CYTR as of Q3 2014.

  • Janney Montgomery Scott reported no remaining CytRx Corp position as of Q3 2014 after selling out during the quarter.
  • Janney Montgomery Scott sold 2,750 CytRx Corp shares in Q3 2014, an estimated $69K.
  • Janney Montgomery Scott first reported a position in CytRx Corp in Q1 2014 and held it in 2 quarters.
  • Janney Montgomery Scott's CytRx Corp position peaked at $69K in Q2 2014.
  • 69 funds tracked by Wall St. Rank held CytRx Corp as of Q3 2014.

Based on Janney Montgomery Scott's 13F filing for Q3 2014, filed 14 Nov 2014.